Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,020 recruiting studies in this area right now.
By phase
- Not applicable2,809
- Phase 2750
- Phase 1522
- Phase 3382
- Phase 1/Phase 2294
- Phase 4204
- Phase 2/Phase 359
Top conditions
- Breast Cancer1,191
- Melanoma173
- Metastatic Breast Cancer138
- Rheumatoid Arthritis131
- Atopic Dermatitis124
- Systemic Lupus Erythematosus119
- Breast Neoplasms111
- Triple Negative Breast Cancer111
- Colorectal Cancer93
- Ovarian Cancer91
- Psoriasis85
- Breast Carcinoma79
- Lung Cancer77
- Prostate Cancer69
- Rheumatoid Arthritis (RA)68
- Diabetic Foot Ulcer59
- Cancer58
- Systemic Lupus Erythematosus (SLE)52
Leading sponsors
- Fudan University64
- M.D. Anderson Cancer Center51
- Novartis Pharmaceuticals49
- Memorial Sloan Kettering Cancer Center48
- Mayo Clinic40
- AstraZeneca38
- Assistance Publique - Hôpitaux de Paris37
- National Cancer Institute (NCI)37
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34
- Second Affiliated Hospital, Zhejiang University, School of Medicine30
Where studies are running
- California408
- Arizona151
- Alabama130
- Florida125
- New York111
- Texas106
- Maryland94
- Massachusetts87
- Pennsylvania72
- North Carolina68
Recruiting studies5,020 total
- NCT07830225Recruiting
Using a blood test to guide how long immunotherapy continues for advanced melanoma
This study looks at using a blood test that detects tiny pieces of cancer DNA (called ctDNA) to help decide how long patients with advanced melanoma should stay on immunotherapy. It may help some patients safely stop treatment earlier if the blood test shows the cancer is under control.
New Brunswick, New JerseyAges 18–90 - NCT04842812RecruitingPhase 1
Personalized immune cell therapy for advanced solid tumors
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
GuangzhouAges 18–85 - NCT03755739RecruitingPhase 2/Phase 3
Checkpoint cancer drug given into or near tumors
This trial studies whether giving immunotherapy “checkpoint inhibitor” medicine directly into the tumor area (and/or the artery feeding it), along with a chemotherapy-style drug, can work better for advanced solid tumors. It aims to boost the immune system’s ability to attack cancer while still being safe for people with measurable tumors.
Guanzhou, GuangdongAges 18 years+ - NCT05187338RecruitingPhase 1/Phase 2
Study drugs that target immune checkpoints for solid tumors
This early-phase study tests a combination of three immune “checkpoint” medicines in people with advanced solid cancers. It aims to see how well they work and what side effects occur, including when given through a specific liver-focused treatment in eligible patients.
Guangzhou, GuangdongAges 18–70 - NCT06472583RecruitingPhase 2
Immunotherapy and radiation before breast cancer surgery
This trial tests giving immunotherapy combined with a precise, high-dose radiation boost before surgery for HER2-negative breast cancer. The goal is to see if this approach can improve outcomes, especially for cancers that are more advanced or have spread to a few other spots in the body.
GliwiceAges 18 years+ - NCT06338735Recruiting
High-frequency ultrasound for Sjögren's diagnosis
This study uses a special, very high-frequency ultrasound to take detailed images of the small glands that can be affected in Sjögren's syndrome. The goal is to see if this new ultrasound technique can help doctors diagnose Sjögren's more accurately.
PisaAges 18 years+ - NCT04790305RecruitingPhase 4
Huaier granules with standard therapy for early triple-negative breast cancer
This trial looks at whether adding Huaier granules to usual after-surgery treatment can improve outcomes for people with high-risk early-stage triple-negative breast cancer. It focuses on whether the added supplement is safe and helpful after standard care.
Hefei, AnhuiAges 18–70 - NCT06008106RecruitingPhase 3
Tunlametinib pill vs chemo for advanced NRAS melanoma
This trial tests a new pill called Tunlametinib (a MEK inhibitor) compared to standard chemotherapy for people with advanced melanoma that has a specific NRAS gene change and no longer responds to immunotherapy. It aims to see if the new pill works better or is safer than chemo.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07820085RecruitingPhase 2/Phase 3
Oral treatment for light sensitivity in EPP and XLP
This study tests an oral medication, PORT-77, to reduce pain and sensitivity to sunlight in people with EPP or XLP. It may help those who experience symptoms shortly after sun exposure.
Huntington Beach, CaliforniaAges 12 years+ - NCT07820397Recruiting
Comparing fat cell health after liposuction
This study looks at how healthy fat cells are after liposuction by comparing fat from two different areas of the body. It aims to help improve fat grafting procedures in the future.
Concord, OhioAges 30–65 - NCT07819435RecruitingPhase 2/Phase 3
Topical treatment for male pattern hair loss
This study tests an investigational topical medication called PP405 for male pattern hair loss. It aims to see if the treatment is safe and effective for regrowing hair in men with moderate balding.
Birmingham, AlabamaAges 18–55 - NCT07820943Recruiting
Moisturizer for dry skin on lower legs
This trial tests a moisturizer to improve dry skin (xerosis) on the lower legs. It aims to increase skin hydration and strengthen the skin barrier, which may help people with moderate to severe dryness.
Osasco, São PauloAges 35–65 - NCT04531696Recruiting
Post-death breast tissue donation study for cancer research
This trial invites adults with certain breast cancer conditions to donate tissue after death. Researchers hope the donated samples will help better understand cancer and improve future treatments.
LeuvenAges 18 years+ - NCT07818525Recruiting
Hormone levels and response to isotretinoin for acne in women
This study looks at how a woman's natural hormone levels affect how well she responds to isotretinoin (a strong acne pill). It aims to help doctors predict which patients will benefit most from this treatment.
Küçükçekmece, IstanbulAges 18–40 - NCT07822360Recruiting
Acne and hormonal imbalance risk in young women
This study looks at how common polyendocrine metabolic ovarian syndrome (PMOS), a hormonal condition, is in women with acne. It aims to find if acne could be a sign of this condition, which might help with early detection and treatment.
SohagAges 15–49 - NCT07823660Recruiting
Heart-healthy exercise during breast cancer chemotherapy
This study tests a supervised exercise program for people with breast cancer who are about to start or are already in chemotherapy. The goal is to see if this type of rehabilitation helps keep your heart strong and improves your overall well-being during treatment.
Porto Alegre, Rio Grande do SulAges 18–65 - NCT07823478Recruiting
Home urine testing for lupus patients
This study tests whether lupus patients can use a home urine test to monitor their kidney health, which could help catch kidney problems early. It is for patients who have lupus and may have had kidney involvement before, or are at risk of developing it.
New York, New YorkAges 18 years+ - NCT05994664Recruiting
Heart Coherence Training for Vascular Ehlers-Danlos
This study tests whether a breathing and heart-rate training program (called Heart Coherence Training) can help people with Vascular Ehlers-Danlos syndrome feel better. It's done from home using your phone and a computer or tablet.
Houston, TexasAges 12–45 - NCT05122039Recruiting
Follow-up study for people with psoriasis
This study follows people with psoriasis over time to better understand the condition and how it changes. You may be able to join if your psoriasis started more than 3 years ago and you can agree to take part.
Leuven, Vlaams-BrabantAges 12–70 - NCT06394063Recruiting
Telitacicept to prevent lupus flares
This trial tests a medicine called Telitacicept to see if it can prevent lupus flares in people whose disease is currently mild or stable. It may be a good option if you want to keep your lupus under control and avoid sudden worsening.
ShanghaiAges 18–70 - NCT05549024RecruitingEarly Phase 1
PET/CT scan study for certain prostate, brain, or breast cancers
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
BeijingAges 18 years+ - NCT07815886Recruiting
Benralizumab for EGPA: a real-world study
This study looks at how well benralizumab (Fasenra) works for people with EGPA, a rare disease that causes inflammation in blood vessels and can affect the lungs, skin, and nerves. By tracking people already on this treatment, researchers hope to learn more about its long-term effectiveness.
Florence, ItalyAges 18 years+ - NCT07811531RecruitingPhase 4
Moisturizer study for adults with sensitive skin
This study tests a moisturizer to see if it helps strengthen the skin's barrier in people with sensitive skin. You'll apply the product twice daily for 28 days and attend clinic visits.
New York, New YorkAges 18–55 - NCT07816328RecruitingPhase 3
New treatment plan for chronic hives not helped by antihistamines
This trial tests a treatment plan using remibrutinib (a pill) and omalizumab (a biologic shot) for adults with chronic spontaneous urticaria (chronic hives) that are not well controlled by antihistamines. The goal is to see if this combination can reduce itching and hives better than current options.
Hong Kong, Hong KongAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,020 recruiting dermatology studies from the U.S. registry right now, out of 7,754 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.